nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—PTGS1—malignant glioma	0.652	1	CbGaD
Eszopiclone—Behavior disorder—Temozolomide—malignant glioma	0.0146	0.0728	CcSEcCtD
Eszopiclone—Zopiclone—PTGS1—malignant glioma	0.00503	1	CrCbGaD
Eszopiclone—Abnormal behaviour—Temozolomide—malignant glioma	0.00451	0.0225	CcSEcCtD
Eszopiclone—Hyperacusis—Temozolomide—malignant glioma	0.00451	0.0225	CcSEcCtD
Eszopiclone—TSPO—blood vessel—malignant glioma	0.00304	0.043	CbGeAlD
Eszopiclone—Myasthenia—Carmustine—malignant glioma	0.00277	0.0138	CcSEcCtD
Eszopiclone—Parosmia—Temozolomide—malignant glioma	0.00259	0.0129	CcSEcCtD
Eszopiclone—Hypokinesia—Carmustine—malignant glioma	0.00258	0.0129	CcSEcCtD
Eszopiclone—Digestion impaired—Temozolomide—malignant glioma	0.00251	0.0126	CcSEcCtD
Eszopiclone—Myopathy—Temozolomide—malignant glioma	0.0024	0.012	CcSEcCtD
Eszopiclone—Apathy—Temozolomide—malignant glioma	0.00235	0.0118	CcSEcCtD
Eszopiclone—Flat affect—Temozolomide—malignant glioma	0.00233	0.0116	CcSEcCtD
Eszopiclone—Stupor—Carmustine—malignant glioma	0.00233	0.0116	CcSEcCtD
Eszopiclone—GABRA5—telencephalon—malignant glioma	0.0023	0.0325	CbGeAlD
Eszopiclone—Menorrhagia—Temozolomide—malignant glioma	0.00227	0.0113	CcSEcCtD
Eszopiclone—Vaginal haemorrhage—Temozolomide—malignant glioma	0.00227	0.0113	CcSEcCtD
Eszopiclone—Herpes zoster—Temozolomide—malignant glioma	0.00223	0.0112	CcSEcCtD
Eszopiclone—Otitis media—Temozolomide—malignant glioma	0.00216	0.0108	CcSEcCtD
Eszopiclone—Hyperaesthesia—Temozolomide—malignant glioma	0.00214	0.0107	CcSEcCtD
Eszopiclone—Memory impairment—Temozolomide—malignant glioma	0.00214	0.0107	CcSEcCtD
Eszopiclone—GABRA4—telencephalon—malignant glioma	0.00209	0.0295	CbGeAlD
Eszopiclone—Speech disorder—Carmustine—malignant glioma	0.00202	0.0101	CcSEcCtD
Eszopiclone—Liver injury—Temozolomide—malignant glioma	0.002	0.00998	CcSEcCtD
Eszopiclone—GABRB2—brainstem—malignant glioma	0.00197	0.0278	CbGeAlD
Eszopiclone—Accidental injury—Carmustine—malignant glioma	0.00197	0.00982	CcSEcCtD
Eszopiclone—Speech disorder—Temozolomide—malignant glioma	0.00195	0.00976	CcSEcCtD
Eszopiclone—Breast pain—Temozolomide—malignant glioma	0.00193	0.00962	CcSEcCtD
Eszopiclone—Amenorrhoea—Temozolomide—malignant glioma	0.00191	0.00956	CcSEcCtD
Eszopiclone—Thinking abnormal—Carmustine—malignant glioma	0.0019	0.00949	CcSEcCtD
Eszopiclone—Viral infection—Temozolomide—malignant glioma	0.00186	0.0093	CcSEcCtD
Eszopiclone—PTGS1—endothelium—malignant glioma	0.00184	0.026	CbGeAlD
Eszopiclone—TSPO—embryo—malignant glioma	0.00181	0.0257	CbGeAlD
Eszopiclone—GABRA2—brainstem—malignant glioma	0.0018	0.0254	CbGeAlD
Eszopiclone—Gait disturbance—Carmustine—malignant glioma	0.00178	0.0089	CcSEcCtD
Eszopiclone—Coordination abnormal—Carmustine—malignant glioma	0.00177	0.00885	CcSEcCtD
Eszopiclone—GABRG2—telencephalon—malignant glioma	0.00175	0.0247	CbGeAlD
Eszopiclone—GABRB2—telencephalon—malignant glioma	0.00175	0.0247	CbGeAlD
Eszopiclone—GABRA1—brainstem—malignant glioma	0.00174	0.0246	CbGeAlD
Eszopiclone—Gait disturbance—Temozolomide—malignant glioma	0.00172	0.0086	CcSEcCtD
Eszopiclone—Coordination abnormal—Temozolomide—malignant glioma	0.00171	0.00855	CcSEcCtD
Eszopiclone—GABRG3—central nervous system—malignant glioma	0.0017	0.0241	CbGeAlD
Eszopiclone—PTGS1—blood vessel—malignant glioma	0.00169	0.024	CbGeAlD
Eszopiclone—Vaginal inflammation—Temozolomide—malignant glioma	0.00168	0.0084	CcSEcCtD
Eszopiclone—Urinary incontinence—Carmustine—malignant glioma	0.00168	0.00839	CcSEcCtD
Eszopiclone—Depressed level of consciousness—Carmustine—malignant glioma	0.00168	0.00839	CcSEcCtD
Eszopiclone—TSPO—brainstem—malignant glioma	0.00166	0.0235	CbGeAlD
Eszopiclone—Neuropathy—Carmustine—malignant glioma	0.00163	0.00816	CcSEcCtD
Eszopiclone—Depressed level of consciousness—Temozolomide—malignant glioma	0.00162	0.00811	CcSEcCtD
Eszopiclone—Urinary incontinence—Temozolomide—malignant glioma	0.00162	0.00811	CcSEcCtD
Eszopiclone—TSPO—retina—malignant glioma	0.0016	0.0227	CbGeAlD
Eszopiclone—GABRA2—telencephalon—malignant glioma	0.00159	0.0226	CbGeAlD
Eszopiclone—Vaginal infection—Temozolomide—malignant glioma	0.00159	0.00793	CcSEcCtD
Eszopiclone—Neuropathy—Temozolomide—malignant glioma	0.00158	0.00788	CcSEcCtD
Eszopiclone—Gynaecomastia—Carmustine—malignant glioma	0.00156	0.00777	CcSEcCtD
Eszopiclone—Dry eye—Temozolomide—malignant glioma	0.00155	0.00776	CcSEcCtD
Eszopiclone—GABRA1—telencephalon—malignant glioma	0.00154	0.0218	CbGeAlD
Eszopiclone—Mental disability—Carmustine—malignant glioma	0.00151	0.00754	CcSEcCtD
Eszopiclone—TSPO—telencephalon—malignant glioma	0.00148	0.0209	CbGeAlD
Eszopiclone—Mental disability—Temozolomide—malignant glioma	0.00146	0.00729	CcSEcCtD
Eszopiclone—Thrombophlebitis—Carmustine—malignant glioma	0.00146	0.00729	CcSEcCtD
Eszopiclone—Swelling—Carmustine—malignant glioma	0.00143	0.00715	CcSEcCtD
Eszopiclone—Ear pain—Temozolomide—malignant glioma	0.00143	0.00714	CcSEcCtD
Eszopiclone—Thrombophlebitis—Temozolomide—malignant glioma	0.00141	0.00704	CcSEcCtD
Eszopiclone—Injury—Carmustine—malignant glioma	0.00137	0.00686	CcSEcCtD
Eszopiclone—GABRG2—medulla oblongata—malignant glioma	0.00137	0.0194	CbGeAlD
Eszopiclone—GABRB2—medulla oblongata—malignant glioma	0.00137	0.0194	CbGeAlD
Eszopiclone—GABRG3—brain—malignant glioma	0.00135	0.0191	CbGeAlD
Eszopiclone—Amnesia—Carmustine—malignant glioma	0.00134	0.00671	CcSEcCtD
Eszopiclone—GABRA5—central nervous system—malignant glioma	0.00131	0.0185	CbGeAlD
Eszopiclone—Amnesia—Temozolomide—malignant glioma	0.0013	0.00649	CcSEcCtD
Eszopiclone—Thirst—Temozolomide—malignant glioma	0.00128	0.0064	CcSEcCtD
Eszopiclone—Diplopia—Carmustine—malignant glioma	0.00126	0.00631	CcSEcCtD
Eszopiclone—GABRG2—midbrain—malignant glioma	0.00125	0.0177	CbGeAlD
Eszopiclone—GABRB2—midbrain—malignant glioma	0.00125	0.0177	CbGeAlD
Eszopiclone—GABRG2—spinal cord—malignant glioma	0.00122	0.0173	CbGeAlD
Eszopiclone—GABRB2—spinal cord—malignant glioma	0.00122	0.0173	CbGeAlD
Eszopiclone—Diplopia—Temozolomide—malignant glioma	0.00122	0.0061	CcSEcCtD
Eszopiclone—Face oedema—Carmustine—malignant glioma	0.00122	0.00609	CcSEcCtD
Eszopiclone—GABRA3—central nervous system—malignant glioma	0.00122	0.0172	CbGeAlD
Eszopiclone—GABRA1—medulla oblongata—malignant glioma	0.00121	0.0171	CbGeAlD
Eszopiclone—Affect lability—Temozolomide—malignant glioma	0.0012	0.006	CcSEcCtD
Eszopiclone—Ataxia—Carmustine—malignant glioma	0.00119	0.00593	CcSEcCtD
Eszopiclone—GABRA4—central nervous system—malignant glioma	0.00119	0.0168	CbGeAlD
Eszopiclone—Face oedema—Temozolomide—malignant glioma	0.00118	0.00588	CcSEcCtD
Eszopiclone—TSPO—medulla oblongata—malignant glioma	0.00116	0.0164	CbGeAlD
Eszopiclone—GABRA4—cerebellum—malignant glioma	0.00116	0.0164	CbGeAlD
Eszopiclone—Mood swings—Temozolomide—malignant glioma	0.00116	0.00577	CcSEcCtD
Eszopiclone—Hypokalaemia—Carmustine—malignant glioma	0.00115	0.00574	CcSEcCtD
Eszopiclone—Ataxia—Temozolomide—malignant glioma	0.00115	0.00573	CcSEcCtD
Eszopiclone—Dehydration—Temozolomide—malignant glioma	0.00113	0.00567	CcSEcCtD
Eszopiclone—Dry skin—Temozolomide—malignant glioma	0.00112	0.00559	CcSEcCtD
Eszopiclone—Muscular weakness—Carmustine—malignant glioma	0.00111	0.00556	CcSEcCtD
Eszopiclone—Hypokalaemia—Temozolomide—malignant glioma	0.00111	0.00555	CcSEcCtD
Eszopiclone—GABRA1—midbrain—malignant glioma	0.00111	0.0157	CbGeAlD
Eszopiclone—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.0011	0.00549	CcSEcCtD
Eszopiclone—Dysphagia—Carmustine—malignant glioma	0.00109	0.00545	CcSEcCtD
Eszopiclone—GABRA1—spinal cord—malignant glioma	0.00108	0.0153	CbGeAlD
Eszopiclone—Muscular weakness—Temozolomide—malignant glioma	0.00108	0.00538	CcSEcCtD
Eszopiclone—TSPO—midbrain—malignant glioma	0.00106	0.015	CbGeAlD
Eszopiclone—Dysphagia—Temozolomide—malignant glioma	0.00105	0.00527	CcSEcCtD
Eszopiclone—GABRA5—brain—malignant glioma	0.00104	0.0147	CbGeAlD
Eszopiclone—TSPO—spinal cord—malignant glioma	0.00103	0.0146	CbGeAlD
Eszopiclone—Bronchitis—Temozolomide—malignant glioma	0.00101	0.00507	CcSEcCtD
Eszopiclone—GABRG2—central nervous system—malignant glioma	0.000992	0.014	CbGeAlD
Eszopiclone—GABRB2—central nervous system—malignant glioma	0.000992	0.014	CbGeAlD
Eszopiclone—Dysuria—Temozolomide—malignant glioma	0.000986	0.00493	CcSEcCtD
Eszopiclone—Pollakiuria—Temozolomide—malignant glioma	0.000974	0.00487	CcSEcCtD
Eszopiclone—Erectile dysfunction—Temozolomide—malignant glioma	0.000971	0.00485	CcSEcCtD
Eszopiclone—Depression—Carmustine—malignant glioma	0.00097	0.00485	CcSEcCtD
Eszopiclone—GABRG2—cerebellum—malignant glioma	0.000969	0.0137	CbGeAlD
Eszopiclone—GABRB2—cerebellum—malignant glioma	0.000969	0.0137	CbGeAlD
Eszopiclone—GABRA3—brain—malignant glioma	0.000966	0.0137	CbGeAlD
Eszopiclone—Photosensitivity reaction—Temozolomide—malignant glioma	0.000962	0.00481	CcSEcCtD
Eszopiclone—Weight increased—Temozolomide—malignant glioma	0.00096	0.00479	CcSEcCtD
Eszopiclone—Weight decreased—Temozolomide—malignant glioma	0.000954	0.00477	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Carmustine—malignant glioma	0.000954	0.00476	CcSEcCtD
Eszopiclone—Stomatitis—Carmustine—malignant glioma	0.000948	0.00474	CcSEcCtD
Eszopiclone—Urinary tract infection—Carmustine—malignant glioma	0.000946	0.00472	CcSEcCtD
Eszopiclone—GABRA4—brain—malignant glioma	0.000941	0.0133	CbGeAlD
Eszopiclone—Depression—Temozolomide—malignant glioma	0.000937	0.00468	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Temozolomide—malignant glioma	0.000922	0.0046	CcSEcCtD
Eszopiclone—Stomatitis—Temozolomide—malignant glioma	0.000916	0.00458	CcSEcCtD
Eszopiclone—Urinary tract infection—Temozolomide—malignant glioma	0.000914	0.00457	CcSEcCtD
Eszopiclone—GABRA2—central nervous system—malignant glioma	0.000906	0.0128	CbGeAlD
Eszopiclone—GABRA2—cerebellum—malignant glioma	0.000886	0.0125	CbGeAlD
Eszopiclone—GABRA1—central nervous system—malignant glioma	0.000876	0.0124	CbGeAlD
Eszopiclone—Hypoaesthesia—Carmustine—malignant glioma	0.000869	0.00434	CcSEcCtD
Eszopiclone—Hallucination—Carmustine—malignant glioma	0.000869	0.00434	CcSEcCtD
Eszopiclone—Oedema peripheral—Carmustine—malignant glioma	0.00086	0.0043	CcSEcCtD
Eszopiclone—GABRA1—cerebellum—malignant glioma	0.000856	0.0121	CbGeAlD
Eszopiclone—Hepatitis—Temozolomide—malignant glioma	0.000844	0.00422	CcSEcCtD
Eszopiclone—Hallucination—Temozolomide—malignant glioma	0.00084	0.0042	CcSEcCtD
Eszopiclone—Hypoaesthesia—Temozolomide—malignant glioma	0.00084	0.0042	CcSEcCtD
Eszopiclone—TSPO—central nervous system—malignant glioma	0.000839	0.0119	CbGeAlD
Eszopiclone—Pharyngitis—Temozolomide—malignant glioma	0.000838	0.00419	CcSEcCtD
Eszopiclone—Oedema peripheral—Temozolomide—malignant glioma	0.000831	0.00415	CcSEcCtD
Eszopiclone—PTGS1—telencephalon—malignant glioma	0.000821	0.0116	CbGeAlD
Eszopiclone—TSPO—cerebellum—malignant glioma	0.00082	0.0116	CbGeAlD
Eszopiclone—Erythema multiforme—Temozolomide—malignant glioma	0.000798	0.00399	CcSEcCtD
Eszopiclone—GABRG2—brain—malignant glioma	0.000787	0.0111	CbGeAlD
Eszopiclone—GABRB2—brain—malignant glioma	0.000787	0.0111	CbGeAlD
Eszopiclone—Tinnitus—Temozolomide—malignant glioma	0.000787	0.00393	CcSEcCtD
Eszopiclone—Alopecia—Carmustine—malignant glioma	0.000772	0.00386	CcSEcCtD
Eszopiclone—Chills—Temozolomide—malignant glioma	0.000757	0.00378	CcSEcCtD
Eszopiclone—Alopecia—Temozolomide—malignant glioma	0.000746	0.00373	CcSEcCtD
Eszopiclone—Back pain—Carmustine—malignant glioma	0.000735	0.00367	CcSEcCtD
Eszopiclone—Dysgeusia—Temozolomide—malignant glioma	0.000719	0.00359	CcSEcCtD
Eszopiclone—GABRA2—brain—malignant glioma	0.000719	0.0102	CbGeAlD
Eszopiclone—Vision blurred—Carmustine—malignant glioma	0.000717	0.00358	CcSEcCtD
Eszopiclone—Tremor—Carmustine—malignant glioma	0.000712	0.00356	CcSEcCtD
Eszopiclone—Back pain—Temozolomide—malignant glioma	0.000711	0.00355	CcSEcCtD
Eszopiclone—Anaemia—Carmustine—malignant glioma	0.000703	0.00351	CcSEcCtD
Eszopiclone—Agitation—Carmustine—malignant glioma	0.000699	0.00349	CcSEcCtD
Eszopiclone—GABRA1—brain—malignant glioma	0.000695	0.00984	CbGeAlD
Eszopiclone—Vision blurred—Temozolomide—malignant glioma	0.000692	0.00346	CcSEcCtD
Eszopiclone—Tremor—Temozolomide—malignant glioma	0.000688	0.00344	CcSEcCtD
Eszopiclone—Ill-defined disorder—Temozolomide—malignant glioma	0.000682	0.00341	CcSEcCtD
Eszopiclone—Anaemia—Temozolomide—malignant glioma	0.000679	0.00339	CcSEcCtD
Eszopiclone—Agitation—Temozolomide—malignant glioma	0.000675	0.00337	CcSEcCtD
Eszopiclone—Angioedema—Temozolomide—malignant glioma	0.000671	0.00335	CcSEcCtD
Eszopiclone—TSPO—brain—malignant glioma	0.000666	0.00942	CbGeAlD
Eszopiclone—Malaise—Temozolomide—malignant glioma	0.000663	0.00331	CcSEcCtD
Eszopiclone—Vertigo—Temozolomide—malignant glioma	0.00066	0.0033	CcSEcCtD
Eszopiclone—Convulsion—Carmustine—malignant glioma	0.000659	0.00329	CcSEcCtD
Eszopiclone—Hypertension—Carmustine—malignant glioma	0.000656	0.00328	CcSEcCtD
Eszopiclone—Palpitations—Temozolomide—malignant glioma	0.000649	0.00324	CcSEcCtD
Eszopiclone—Myalgia—Carmustine—malignant glioma	0.000647	0.00323	CcSEcCtD
Eszopiclone—Chest pain—Carmustine—malignant glioma	0.000647	0.00323	CcSEcCtD
Eszopiclone—Anxiety—Carmustine—malignant glioma	0.000645	0.00322	CcSEcCtD
Eszopiclone—Convulsion—Temozolomide—malignant glioma	0.000637	0.00318	CcSEcCtD
Eszopiclone—Hypertension—Temozolomide—malignant glioma	0.000634	0.00317	CcSEcCtD
Eszopiclone—Confusional state—Carmustine—malignant glioma	0.000626	0.00313	CcSEcCtD
Eszopiclone—Myalgia—Temozolomide—malignant glioma	0.000626	0.00313	CcSEcCtD
Eszopiclone—Anxiety—Temozolomide—malignant glioma	0.000623	0.00311	CcSEcCtD
Eszopiclone—Discomfort—Temozolomide—malignant glioma	0.000618	0.00309	CcSEcCtD
Eszopiclone—Infection—Carmustine—malignant glioma	0.000616	0.00308	CcSEcCtD
Eszopiclone—Dry mouth—Temozolomide—malignant glioma	0.000612	0.00306	CcSEcCtD
Eszopiclone—Tachycardia—Carmustine—malignant glioma	0.000606	0.00303	CcSEcCtD
Eszopiclone—Confusional state—Temozolomide—malignant glioma	0.000605	0.00302	CcSEcCtD
Eszopiclone—Anaphylactic shock—Temozolomide—malignant glioma	0.0006	0.003	CcSEcCtD
Eszopiclone—Infection—Temozolomide—malignant glioma	0.000596	0.00298	CcSEcCtD
Eszopiclone—Anorexia—Carmustine—malignant glioma	0.000591	0.00295	CcSEcCtD
Eszopiclone—Hyperhidrosis—Temozolomide—malignant glioma	0.00058	0.0029	CcSEcCtD
Eszopiclone—PTGS1—spinal cord—malignant glioma	0.000575	0.00814	CbGeAlD
Eszopiclone—Anorexia—Temozolomide—malignant glioma	0.000572	0.00286	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000565	0.00282	CcSEcCtD
Eszopiclone—Insomnia—Carmustine—malignant glioma	0.000561	0.0028	CcSEcCtD
Eszopiclone—Paraesthesia—Carmustine—malignant glioma	0.000557	0.00278	CcSEcCtD
Eszopiclone—Dyspnoea—Carmustine—malignant glioma	0.000553	0.00276	CcSEcCtD
Eszopiclone—Somnolence—Carmustine—malignant glioma	0.000552	0.00276	CcSEcCtD
Eszopiclone—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000546	0.00273	CcSEcCtD
Eszopiclone—Insomnia—Temozolomide—malignant glioma	0.000542	0.00271	CcSEcCtD
Eszopiclone—Decreased appetite—Carmustine—malignant glioma	0.000539	0.00269	CcSEcCtD
Eszopiclone—Paraesthesia—Temozolomide—malignant glioma	0.000538	0.00269	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Carmustine—malignant glioma	0.000536	0.00268	CcSEcCtD
Eszopiclone—Dyspnoea—Temozolomide—malignant glioma	0.000535	0.00267	CcSEcCtD
Eszopiclone—Somnolence—Temozolomide—malignant glioma	0.000533	0.00266	CcSEcCtD
Eszopiclone—Constipation—Carmustine—malignant glioma	0.000531	0.00265	CcSEcCtD
Eszopiclone—Pain—Carmustine—malignant glioma	0.000531	0.00265	CcSEcCtD
Eszopiclone—Dyspepsia—Temozolomide—malignant glioma	0.000528	0.00264	CcSEcCtD
Eszopiclone—Decreased appetite—Temozolomide—malignant glioma	0.000521	0.0026	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000518	0.00259	CcSEcCtD
Eszopiclone—Fatigue—Temozolomide—malignant glioma	0.000517	0.00258	CcSEcCtD
Eszopiclone—Pain—Temozolomide—malignant glioma	0.000513	0.00256	CcSEcCtD
Eszopiclone—Constipation—Temozolomide—malignant glioma	0.000513	0.00256	CcSEcCtD
Eszopiclone—Feeling abnormal—Carmustine—malignant glioma	0.000511	0.00255	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Carmustine—malignant glioma	0.000507	0.00253	CcSEcCtD
Eszopiclone—Feeling abnormal—Temozolomide—malignant glioma	0.000494	0.00247	CcSEcCtD
Eszopiclone—Abdominal pain—Carmustine—malignant glioma	0.000491	0.00245	CcSEcCtD
Eszopiclone—Body temperature increased—Carmustine—malignant glioma	0.000491	0.00245	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Temozolomide—malignant glioma	0.00049	0.00245	CcSEcCtD
Eszopiclone—Urticaria—Temozolomide—malignant glioma	0.000476	0.00238	CcSEcCtD
Eszopiclone—Body temperature increased—Temozolomide—malignant glioma	0.000474	0.00237	CcSEcCtD
Eszopiclone—Abdominal pain—Temozolomide—malignant glioma	0.000474	0.00237	CcSEcCtD
Eszopiclone—PTGS1—central nervous system—malignant glioma	0.000467	0.0066	CbGeAlD
Eszopiclone—Hypersensitivity—Carmustine—malignant glioma	0.000457	0.00228	CcSEcCtD
Eszopiclone—CYP2C8—brain—malignant glioma	0.000457	0.00647	CbGeAlD
Eszopiclone—Asthenia—Carmustine—malignant glioma	0.000445	0.00222	CcSEcCtD
Eszopiclone—Hypersensitivity—Temozolomide—malignant glioma	0.000442	0.00221	CcSEcCtD
Eszopiclone—Asthenia—Temozolomide—malignant glioma	0.00043	0.00215	CcSEcCtD
Eszopiclone—Diarrhoea—Carmustine—malignant glioma	0.000425	0.00212	CcSEcCtD
Eszopiclone—Pruritus—Temozolomide—malignant glioma	0.000424	0.00212	CcSEcCtD
Eszopiclone—Dizziness—Carmustine—malignant glioma	0.00041	0.00205	CcSEcCtD
Eszopiclone—Diarrhoea—Temozolomide—malignant glioma	0.00041	0.00205	CcSEcCtD
Eszopiclone—Dizziness—Temozolomide—malignant glioma	0.000397	0.00198	CcSEcCtD
Eszopiclone—Vomiting—Carmustine—malignant glioma	0.000395	0.00197	CcSEcCtD
Eszopiclone—Rash—Carmustine—malignant glioma	0.000391	0.00195	CcSEcCtD
Eszopiclone—Dermatitis—Carmustine—malignant glioma	0.000391	0.00195	CcSEcCtD
Eszopiclone—CYP3A4—central nervous system—malignant glioma	0.00039	0.00552	CbGeAlD
Eszopiclone—Headache—Carmustine—malignant glioma	0.000389	0.00194	CcSEcCtD
Eszopiclone—Vomiting—Temozolomide—malignant glioma	0.000381	0.0019	CcSEcCtD
Eszopiclone—Rash—Temozolomide—malignant glioma	0.000378	0.00189	CcSEcCtD
Eszopiclone—Dermatitis—Temozolomide—malignant glioma	0.000378	0.00189	CcSEcCtD
Eszopiclone—Headache—Temozolomide—malignant glioma	0.000376	0.00188	CcSEcCtD
Eszopiclone—PTGS1—brain—malignant glioma	0.000371	0.00524	CbGeAlD
Eszopiclone—Nausea—Carmustine—malignant glioma	0.000369	0.00184	CcSEcCtD
Eszopiclone—Nausea—Temozolomide—malignant glioma	0.000356	0.00178	CcSEcCtD
Eszopiclone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	8.75e-05	0.00122	CbGpPWpGaD
Eszopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	8.73e-05	0.00122	CbGpPWpGaD
Eszopiclone—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	8.7e-05	0.00121	CbGpPWpGaD
Eszopiclone—PTGS1—Selenium Micronutrient Network—IL1B—malignant glioma	8.63e-05	0.0012	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—TFRC—malignant glioma	8.62e-05	0.0012	CbGpPWpGaD
Eszopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	8.52e-05	0.00119	CbGpPWpGaD
Eszopiclone—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	8.49e-05	0.00118	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—BRAF—malignant glioma	8.36e-05	0.00117	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—MDM2—malignant glioma	8.32e-05	0.00116	CbGpPWpGaD
Eszopiclone—GABRG3—Transmission across Chemical Synapses—RAF1—malignant glioma	8.29e-05	0.00116	CbGpPWpGaD
Eszopiclone—GABRB2—Ion channel transport—RAF1—malignant glioma	8.26e-05	0.00115	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—BRAF—malignant glioma	8.12e-05	0.00113	CbGpPWpGaD
Eszopiclone—GABRA5—Ion channel transport—RAF1—malignant glioma	8.02e-05	0.00112	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—BRAF—malignant glioma	7.97e-05	0.00111	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—GSTT1—malignant glioma	7.94e-05	0.00111	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—TFRC—malignant glioma	7.93e-05	0.00111	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	7.92e-05	0.0011	CbGpPWpGaD
Eszopiclone—GABRA3—Ion channel transport—RAF1—malignant glioma	7.88e-05	0.0011	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—BRAF—malignant glioma	7.84e-05	0.00109	CbGpPWpGaD
Eszopiclone—GABRA2—Ion channel transport—RAF1—malignant glioma	7.74e-05	0.00108	CbGpPWpGaD
Eszopiclone—CYP2C9—Arachidonic acid metabolism—PTGS2—malignant glioma	7.67e-05	0.00107	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—MDM2—malignant glioma	7.66e-05	0.00107	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—BRAF—malignant glioma	7.64e-05	0.00107	CbGpPWpGaD
Eszopiclone—GABRA4—Transmission across Chemical Synapses—RAF1—malignant glioma	7.63e-05	0.00106	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—BRAF—malignant glioma	7.61e-05	0.00106	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	7.57e-05	0.00106	CbGpPWpGaD
Eszopiclone—GABRG2—Ion channel transport—RAF1—malignant glioma	7.55e-05	0.00105	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	7.54e-05	0.00105	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	7.47e-05	0.00104	CbGpPWpGaD
Eszopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—malignant glioma	7.45e-05	0.00104	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—PTGS1—malignant glioma	7.44e-05	0.00104	CbGpPWpGaD
Eszopiclone—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—malignant glioma	7.42e-05	0.00103	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	7.37e-05	0.00103	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	7.32e-05	0.00102	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—SLC5A5—malignant glioma	7.29e-05	0.00102	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—TFRC—malignant glioma	7.26e-05	0.00101	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—TFRC—malignant glioma	7.05e-05	0.000983	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—MDM2—malignant glioma	7e-05	0.000976	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—BRAF—malignant glioma	7e-05	0.000976	CbGpPWpGaD
Eszopiclone—GABRB2—Transmission across Chemical Synapses—RAF1—malignant glioma	6.98e-05	0.000973	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.93e-05	0.000967	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—TFRC—malignant glioma	6.92e-05	0.000965	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—RTEL1—malignant glioma	6.84e-05	0.000954	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—TFRC—malignant glioma	6.8e-05	0.000949	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—MDM2—malignant glioma	6.8e-05	0.000949	CbGpPWpGaD
Eszopiclone—GABRA5—Transmission across Chemical Synapses—RAF1—malignant glioma	6.78e-05	0.000945	CbGpPWpGaD
Eszopiclone—CYP2C8—Biological oxidations—GSTP1—malignant glioma	6.77e-05	0.000943	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—BRAF—malignant glioma	6.68e-05	0.000932	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—MDM2—malignant glioma	6.68e-05	0.000931	CbGpPWpGaD
Eszopiclone—CYP2C8—Metapathway biotransformation—GSTP1—malignant glioma	6.67e-05	0.000931	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.66e-05	0.000929	CbGpPWpGaD
Eszopiclone—GABRA3—Transmission across Chemical Synapses—RAF1—malignant glioma	6.66e-05	0.000928	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—TFRC—malignant glioma	6.64e-05	0.000925	CbGpPWpGaD
Eszopiclone—GABRA1—Ion channel transport—RAF1—malignant glioma	6.6e-05	0.000921	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—MDM2—malignant glioma	6.56e-05	0.000915	CbGpPWpGaD
Eszopiclone—GABRA2—Transmission across Chemical Synapses—RAF1—malignant glioma	6.54e-05	0.000912	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	6.48e-05	0.000903	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.47e-05	0.000903	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—MDM2—malignant glioma	6.4e-05	0.000893	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—BRAF—malignant glioma	6.4e-05	0.000893	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	6.39e-05	0.000891	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—CXCL8—malignant glioma	6.38e-05	0.00089	CbGpPWpGaD
Eszopiclone—GABRG2—Transmission across Chemical Synapses—RAF1—malignant glioma	6.38e-05	0.00089	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—MDM2—malignant glioma	6.37e-05	0.000889	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.36e-05	0.000886	CbGpPWpGaD
Eszopiclone—GABRG3—Neuronal System—RAF1—malignant glioma	6.35e-05	0.000886	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.34e-05	0.000884	CbGpPWpGaD
Eszopiclone—PTGS1—Selenium Micronutrient Network—TNF—malignant glioma	6.26e-05	0.000873	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.25e-05	0.000871	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—BRAF—malignant glioma	6.22e-05	0.000867	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.16e-05	0.000859	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—IL1B—malignant glioma	6.12e-05	0.000854	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—CASP3—malignant glioma	6.11e-05	0.000852	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—BRAF—malignant glioma	6.11e-05	0.000852	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC5A5—malignant glioma	6.09e-05	0.00085	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—COX8A—malignant glioma	6.08e-05	0.000848	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—SLC6A3—malignant glioma	6.05e-05	0.000844	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—BRAF—malignant glioma	6e-05	0.000837	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	5.95e-05	0.000829	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—MDM2—malignant glioma	5.87e-05	0.000818	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—BRAF—malignant glioma	5.86e-05	0.000817	CbGpPWpGaD
Eszopiclone—GABRA4—Neuronal System—RAF1—malignant glioma	5.85e-05	0.000815	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—SLC6A3—malignant glioma	5.8e-05	0.000809	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—TFRC—malignant glioma	5.8e-05	0.000809	CbGpPWpGaD
Eszopiclone—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	5.61e-05	0.000782	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—MDM2—malignant glioma	5.6e-05	0.000781	CbGpPWpGaD
Eszopiclone—GABRA1—Transmission across Chemical Synapses—RAF1—malignant glioma	5.58e-05	0.000778	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—RTEL1—malignant glioma	5.57e-05	0.000776	CbGpPWpGaD
Eszopiclone—CYP2C9—Biological oxidations—GSTP1—malignant glioma	5.51e-05	0.000768	CbGpPWpGaD
Eszopiclone—CYP2C9—Metapathway biotransformation—GSTP1—malignant glioma	5.43e-05	0.000757	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—MDM2—malignant glioma	5.36e-05	0.000748	CbGpPWpGaD
Eszopiclone—GABRB2—Neuronal System—RAF1—malignant glioma	5.35e-05	0.000746	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC5A5—malignant glioma	5.33e-05	0.000743	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTT1—malignant glioma	5.24e-05	0.000731	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—MDM2—malignant glioma	5.21e-05	0.000727	CbGpPWpGaD
Eszopiclone—GABRA5—Neuronal System—RAF1—malignant glioma	5.19e-05	0.000724	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—VEGFA—malignant glioma	5.19e-05	0.000723	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—ASMT—malignant glioma	5.17e-05	0.000721	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—BRAF—malignant glioma	5.12e-05	0.000714	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—MDM2—malignant glioma	5.12e-05	0.000714	CbGpPWpGaD
Eszopiclone—GABRA3—Neuronal System—RAF1—malignant glioma	5.1e-05	0.000711	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—SLC6A3—malignant glioma	5.07e-05	0.000707	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	5.06e-05	0.000705	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—MDM2—malignant glioma	5.03e-05	0.000701	CbGpPWpGaD
Eszopiclone—GABRA2—Neuronal System—RAF1—malignant glioma	5.01e-05	0.000699	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—PTGS1—malignant glioma	4.91e-05	0.000685	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—MDM2—malignant glioma	4.91e-05	0.000684	CbGpPWpGaD
Eszopiclone—GABRG2—Neuronal System—RAF1—malignant glioma	4.89e-05	0.000682	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	4.89e-05	0.000682	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—BCAN—malignant glioma	4.86e-05	0.000678	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	4.73e-05	0.00066	CbGpPWpGaD
Eszopiclone—GABRA1—SIDS Susceptibility Pathways—TNF—malignant glioma	4.44e-05	0.00062	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—MDM2—malignant glioma	4.29e-05	0.000598	CbGpPWpGaD
Eszopiclone—GABRA1—Neuronal System—RAF1—malignant glioma	4.27e-05	0.000596	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—malignant glioma	3.98e-05	0.000555	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—COX8A—malignant glioma	3.93e-05	0.000548	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—IDH2—malignant glioma	3.92e-05	0.000547	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—SPHK1—malignant glioma	3.85e-05	0.000537	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	3.7e-05	0.000515	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP2B6—malignant glioma	3.69e-05	0.000514	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—RTEL1—malignant glioma	3.67e-05	0.000512	CbGpPWpGaD
Eszopiclone—CYP3A4—Biological oxidations—GSTP1—malignant glioma	3.63e-05	0.000506	CbGpPWpGaD
Eszopiclone—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	3.58e-05	0.000499	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	3.51e-05	0.00049	CbGpPWpGaD
Eszopiclone—GABRG3—Transmembrane transport of small molecules—RAF1—malignant glioma	3.42e-05	0.000476	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—IDH1—malignant glioma	3.37e-05	0.00047	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—ASMT—malignant glioma	3.34e-05	0.000466	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	3.27e-05	0.000455	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SPHK1—malignant glioma	3.26e-05	0.000455	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—COX8A—malignant glioma	3.2e-05	0.000446	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CYP2C18—malignant glioma	3.2e-05	0.000446	CbGpPWpGaD
Eszopiclone—GABRA4—Transmembrane transport of small molecules—RAF1—malignant glioma	3.14e-05	0.000438	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—BCAN—malignant glioma	3.14e-05	0.000438	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	3.01e-05	0.00042	CbGpPWpGaD
Eszopiclone—GABRB2—Transmembrane transport of small molecules—RAF1—malignant glioma	2.87e-05	0.000401	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—malignant glioma	2.86e-05	0.000399	CbGpPWpGaD
Eszopiclone—GABRA5—Transmembrane transport of small molecules—RAF1—malignant glioma	2.79e-05	0.000389	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	2.74e-05	0.000383	CbGpPWpGaD
Eszopiclone—GABRA3—Transmembrane transport of small molecules—RAF1—malignant glioma	2.74e-05	0.000382	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—ASMT—malignant glioma	2.72e-05	0.000379	CbGpPWpGaD
Eszopiclone—GABRA2—Transmembrane transport of small molecules—RAF1—malignant glioma	2.69e-05	0.000376	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—malignant glioma	2.66e-05	0.000371	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	2.65e-05	0.000369	CbGpPWpGaD
Eszopiclone—GABRG2—Transmembrane transport of small molecules—RAF1—malignant glioma	2.63e-05	0.000367	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTT1—malignant glioma	2.58e-05	0.00036	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—BCAN—malignant glioma	2.56e-05	0.000356	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—IDH2—malignant glioma	2.53e-05	0.000353	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	2.41e-05	0.000336	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	2.39e-05	0.000333	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP2B6—malignant glioma	2.38e-05	0.000332	CbGpPWpGaD
Eszopiclone—GABRA1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.3e-05	0.00032	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—BCHE—malignant glioma	2.25e-05	0.000314	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—SLC5A5—malignant glioma	2.22e-05	0.00031	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—IDH1—malignant glioma	2.18e-05	0.000304	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—COX8A—malignant glioma	2.11e-05	0.000294	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SPHK1—malignant glioma	2.11e-05	0.000294	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	2.1e-05	0.000293	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	2.08e-05	0.000291	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CYP2C18—malignant glioma	2.06e-05	0.000288	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—IDH2—malignant glioma	2.06e-05	0.000287	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.95e-05	0.000271	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—malignant glioma	1.94e-05	0.000271	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP2B6—malignant glioma	1.94e-05	0.00027	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.82e-05	0.000253	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—ASMT—malignant glioma	1.79e-05	0.00025	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—GSTP1—malignant glioma	1.79e-05	0.00025	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.77e-05	0.000247	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—IDH1—malignant glioma	1.77e-05	0.000247	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CAT—malignant glioma	1.74e-05	0.000243	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SPHK1—malignant glioma	1.71e-05	0.000239	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.71e-05	0.000239	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—BCAN—malignant glioma	1.69e-05	0.000235	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CYP2C18—malignant glioma	1.68e-05	0.000234	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTT1—malignant glioma	1.67e-05	0.000233	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—NCOR1—malignant glioma	1.65e-05	0.00023	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—malignant glioma	1.58e-05	0.000221	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PTGS1—malignant glioma	1.56e-05	0.000218	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.56e-05	0.000217	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—BCHE—malignant glioma	1.45e-05	0.000203	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—malignant glioma	1.44e-05	0.000201	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—SLC5A5—malignant glioma	1.44e-05	0.0002	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—malignant glioma	1.39e-05	0.000194	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—IDH2—malignant glioma	1.36e-05	0.00019	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTT1—malignant glioma	1.36e-05	0.000189	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.36e-05	0.000189	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.35e-05	0.000188	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—CAV1—malignant glioma	1.34e-05	0.000187	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	1.28e-05	0.000179	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.28e-05	0.000178	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PTGS1—malignant glioma	1.27e-05	0.000178	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—malignant glioma	1.27e-05	0.000177	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CG—malignant glioma	1.22e-05	0.00017	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—BCHE—malignant glioma	1.18e-05	0.000165	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PPARG—malignant glioma	1.18e-05	0.000165	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	1.17e-05	0.000164	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—SLC5A5—malignant glioma	1.17e-05	0.000163	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—IDH1—malignant glioma	1.17e-05	0.000163	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—GSTP1—malignant glioma	1.16e-05	0.000161	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SPHK1—malignant glioma	1.13e-05	0.000158	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CAT—malignant glioma	1.13e-05	0.000157	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.11e-05	0.000154	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—malignant glioma	1.11e-05	0.000154	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—malignant glioma	1.1e-05	0.000153	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CD—malignant glioma	1.07e-05	0.00015	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—NCOR1—malignant glioma	1.06e-05	0.000148	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—malignant glioma	9.55e-06	0.000133	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—GSTP1—malignant glioma	9.42e-06	0.000131	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CB—malignant glioma	9.37e-06	0.000131	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PTGS2—malignant glioma	9.28e-06	0.000129	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CAT—malignant glioma	9.16e-06	0.000128	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTT1—malignant glioma	8.96e-06	0.000125	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—CAV1—malignant glioma	8.67e-06	0.000121	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—NCOR1—malignant glioma	8.65e-06	0.000121	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PTGS1—malignant glioma	8.4e-06	0.000117	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	8.28e-06	0.000115	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PTEN—malignant glioma	8.09e-06	0.000113	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CG—malignant glioma	7.9e-06	0.00011	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—BCHE—malignant glioma	7.81e-06	0.000109	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—SLC5A5—malignant glioma	7.71e-06	0.000108	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PPARG—malignant glioma	7.62e-06	0.000106	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—CAV1—malignant glioma	7.05e-06	9.84e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CD—malignant glioma	6.94e-06	9.68e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—malignant glioma	6.74e-06	9.4e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CG—malignant glioma	6.43e-06	8.96e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—GSTP1—malignant glioma	6.21e-06	8.66e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PPARG—malignant glioma	6.2e-06	8.65e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CB—malignant glioma	6.05e-06	8.44e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CAT—malignant glioma	6.04e-06	8.43e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PTGS2—malignant glioma	5.99e-06	8.36e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—PIK3CA—malignant glioma	5.71e-06	7.96e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—NCOR1—malignant glioma	5.71e-06	7.96e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CD—malignant glioma	5.65e-06	7.88e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PTEN—malignant glioma	5.23e-06	7.29e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CB—malignant glioma	4.92e-06	6.87e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PTGS2—malignant glioma	4.88e-06	6.8e-05	CbGpPWpGaD
Eszopiclone—PTGS1—Metabolism—AKT1—malignant glioma	4.66e-06	6.5e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—CAV1—malignant glioma	4.65e-06	6.49e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PTEN—malignant glioma	4.25e-06	5.93e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CG—malignant glioma	4.24e-06	5.91e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PPARG—malignant glioma	4.09e-06	5.7e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.73e-06	5.2e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—PIK3CA—malignant glioma	3.69e-06	5.14e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.25e-06	4.53e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PTGS2—malignant glioma	3.22e-06	4.49e-05	CbGpPWpGaD
Eszopiclone—CYP2C8—Metabolism—AKT1—malignant glioma	3.01e-06	4.2e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—PIK3CA—malignant glioma	3e-06	4.19e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PTEN—malignant glioma	2.81e-06	3.91e-05	CbGpPWpGaD
Eszopiclone—CYP2C9—Metabolism—AKT1—malignant glioma	2.45e-06	3.42e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.98e-06	2.76e-05	CbGpPWpGaD
Eszopiclone—CYP3A4—Metabolism—AKT1—malignant glioma	1.62e-06	2.26e-05	CbGpPWpGaD
